Baltimore-based Camden Partners spins off Nexus biomedical technology group as Catalio Capital Management

The Nexus division of Baltimore-based private equity firm Camden Partners Holdings has spun off as Catalio Capital Management and rebranded to continue investing in biomedical technology firms.

from Baltimore Sun
via https://baltimorecheckbook.tumblr.com/post/621854355283492864